TY - JOUR
T1 - Noninvasive assessment of stenotic severity and plaque characteristics by coronary CT angiography in patients scheduled for carotid artery revascularization
AU - Hoshino, Meiko
AU - Kawai, Hideki
AU - Sarai, Masayoshi
AU - Sadato, Akiyo
AU - Hayakawa, Motoharu
AU - Motoyama, Sadako
AU - Nagahara, Yasuomi
AU - Miyajima, Keiichi
AU - Takahashi, Hiroshi
AU - Ishii, Junnichi
AU - Nakahara, Ichiro
AU - Hirose, Yuichi
AU - Ozaki, Yukio
N1 - Publisher Copyright:
© 2018 Japan Atherosclerosis Society.
PY - 2018
Y1 - 2018
N2 - Aims: Coronary artery atherosclerosis in patients needing carotid revascularization has not been fully clarified. The aim of this study was to evaluate the stenotic severity and plaque characteristics of coronary arteries by coronary computed tomography angiography (CTA) in patients scheduled for carotid-artery stenting (CAS) or carotid endarterectomy (CEA). Methods: We performed coronary CTA after carotid ultrasound (US) in 164 patients (81.7% male, aged 68.1± 12.2 years) from 2014 to 2016. Of all, 70 were scheduled for CAS or CEA (CAS/CEA group) and 94 were not (non-CAS/CEA group). Carotid US and coronary CTA were compared for the evaluation of stenotic severity and plaque characteristics of each vessel between CAS/CEA and non-CAS/CEA groups. Results: Between the two groups, there were significant differences in the presence of significant stenosis (SS: ≥ 70% stenosis of coronary artery) (55.7% vs. 39.4%, P =0.038), triple-vessel disease (TVD)/left main trunk (LMT) (SS in each of three epicardial vessels and/or LMT) (24.3% vs. 7.5%, P = 0.0025), and high-risk plaque (HRP: positive remodeling and/or low attenuation) (55.7% vs. 24.5%, P <0.0001). CAS/CEA was independently associated with TVD/LMT (OR = 2.30, 95%CI: 1.14 – 8.59, P = 0.026) and HRP (OR = 3.17, 95%CI: 1.57 – 6.54, P = 0.0012) in multivariable logistic regression analysis. Similarly, vulnerable plaque (78.6% vs. 2.1%, P <0.0001) as well as severe stenosis of carotid artery (98.6% vs. 0%, P <0.0001) was seen more often in CAS/CEA than in non-CAS/CEA group. Conclusions: The prevalence of TVD/LMT and HRP determined by coronary CTA is higher in patients needing CAS/CEA than in those without. Management of systemic atherosclerosis is required in the perioperative period of CAS/CEA.
AB - Aims: Coronary artery atherosclerosis in patients needing carotid revascularization has not been fully clarified. The aim of this study was to evaluate the stenotic severity and plaque characteristics of coronary arteries by coronary computed tomography angiography (CTA) in patients scheduled for carotid-artery stenting (CAS) or carotid endarterectomy (CEA). Methods: We performed coronary CTA after carotid ultrasound (US) in 164 patients (81.7% male, aged 68.1± 12.2 years) from 2014 to 2016. Of all, 70 were scheduled for CAS or CEA (CAS/CEA group) and 94 were not (non-CAS/CEA group). Carotid US and coronary CTA were compared for the evaluation of stenotic severity and plaque characteristics of each vessel between CAS/CEA and non-CAS/CEA groups. Results: Between the two groups, there were significant differences in the presence of significant stenosis (SS: ≥ 70% stenosis of coronary artery) (55.7% vs. 39.4%, P =0.038), triple-vessel disease (TVD)/left main trunk (LMT) (SS in each of three epicardial vessels and/or LMT) (24.3% vs. 7.5%, P = 0.0025), and high-risk plaque (HRP: positive remodeling and/or low attenuation) (55.7% vs. 24.5%, P <0.0001). CAS/CEA was independently associated with TVD/LMT (OR = 2.30, 95%CI: 1.14 – 8.59, P = 0.026) and HRP (OR = 3.17, 95%CI: 1.57 – 6.54, P = 0.0012) in multivariable logistic regression analysis. Similarly, vulnerable plaque (78.6% vs. 2.1%, P <0.0001) as well as severe stenosis of carotid artery (98.6% vs. 0%, P <0.0001) was seen more often in CAS/CEA than in non-CAS/CEA group. Conclusions: The prevalence of TVD/LMT and HRP determined by coronary CTA is higher in patients needing CAS/CEA than in those without. Management of systemic atherosclerosis is required in the perioperative period of CAS/CEA.
UR - http://www.scopus.com/inward/record.url?scp=85055603768&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055603768&partnerID=8YFLogxK
U2 - 10.5551/jat.42176
DO - 10.5551/jat.42176
M3 - Article
C2 - 29459518
AN - SCOPUS:85055603768
SN - 1340-3478
VL - 25
SP - 1022
EP - 1031
JO - Journal of atherosclerosis and thrombosis
JF - Journal of atherosclerosis and thrombosis
IS - 10
ER -